Abionyx Pharma SA (ABNX PA) stock market data APIs
€3.8692
0.03(0.8%)
as of September 17, 2025
Try our APIs with
free plan!
Abionyx Pharma SA Financial Data Overview
Price chart is built with
Anychart
ABIONYX Pharma SA, a biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases. It develops CER-001, a negatively-charged lipoprotein particle that contains human recombinant apoA-I, the natural high-density lipoprotein (HDL) protein, and sphingomyelin and dipalmitoylphosphatidylglycerol natural phospholipids designed to mimic the structural and functional biological properties of pre-beta HDL for the treatment of post-acute coronary syndrome patients and familial primary hypoalphalipoproteinemia patients; CER-002, a peroxisome proliferator-activated receptor delta specific agonist for the treatment of cardiovascular and metabolic diseases; and CER-209, a drug candidate for the treatment of metabolic diseases in the liver, as well as atherosclerois and non-alcoholic steato-hepatitis (NASH). The company was formerly known as Cerenis Therapeutics Holding SA and changed its name to ABIONYX Pharma SA in August 2019. ABIONYX Pharma SA was founded in 2005 and is headquartered in Balma, France.
Prev. Close
3.8692
Open
3.899
High
3.9938
Low
3.8335
52 wk Range
1.086-4.66
Market Cap
139 M
Shares Outstanding
34 737 K
Revenue
4 551 K
EPS
0
Beta
1.303
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Abionyx Pharma SA data using free add-ons & libraries
Get Abionyx Pharma SA Fundamental Data
Abionyx Pharma SA Fundamental data includes:
- Net Revenue: 4 551 K
- EBITDA: -4 340 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-28
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Abionyx Pharma SA News
New
European Penny Stocks: 3 Promising Picks With At Least €40M Market Cap
The European stock market has shown resilience amid global trade tensions, with the pan-European STOXX Europe 600 Index ending higher due to hopes for new trade deals, despite recent tariff threats. I...
Pharming Group Announces the Nomination of Barbara Yanni and Mark Pykett to the Board of Supervisory Directors
LEIDEN, Netherlands, May 20, 2020 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) announces the nomination of Barbara Yanni and Mark Pykett to its Board o...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
